The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium.
暂无分享,去创建一个
Steffen Jung | K. Ley | M. Sperandio | C. Weber | M. Mack | D. Littman | Y. Huo | Y. Huo | K Ley | J Thatte | D R Littman | M Sperandio | S. Forlow | S B Forlow | Y Huo | C Weber | M Mack | S Jung | J. Thatte | S. Jung | Yuqing Huo
[1] Mark Tidswell,et al. Presentation of Integrins on Leukocyte Microvilli: A Role for the Extracellular Domain in Determining Membrane Localization , 1997, The Journal of cell biology.
[2] T. Springer,et al. Role of alpha L beta 2 integrin avidity in transendothelial chemotaxis of mononuclear cells. , 1997, Journal of immunology.
[3] T. Springer,et al. Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis , 1996, The Journal of cell biology.
[4] T. Schall,et al. Local expression of inflammatory cytokines in human atherosclerotic plaques. , 1994, Journal of atherosclerosis and thrombosis.
[5] E. Butcher,et al. Chemokines and the arrest of lymphocytes rolling under flow conditions. , 1998, Science.
[6] M. Cybulsky,et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. , 1999, Circulation research.
[7] Amnon Peled,et al. Subsecond Induction of α4 Integrin Clustering by Immobilized Chemokines Stimulates Leukocyte Tethering and Rolling on Endothelial Vascular Cell Adhesion Molecule 1 under Flow Conditions , 2000, The Journal of experimental medicine.
[8] P. Murphy,et al. The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor* , 1996, The Journal of Biological Chemistry.
[9] A. Sher,et al. Analysis of Fractalkine Receptor CX3CR1 Function by Targeted Deletion and Green Fluorescent Protein Reporter Gene Insertion , 2000, Molecular and Cellular Biology.
[10] P. Murphy,et al. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. , 1996, The Journal of biological chemistry.
[11] K. Ley,et al. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. , 1999, Circulation research.
[12] A. Beaudet,et al. P-Selectin or Intercellular Adhesion Molecule (Icam)-1 Deficiency Substantially Protects against Atherosclerosis in Apolipoprotein E–Deficient Mice , 2000, The Journal of experimental medicine.
[13] YuqingHuo,et al. Role of Vascular Cell Adhesion Molecule-1 and Fibronectin Connecting Segment-1 in Monocyte Rolling and Adhesion on Early Atherosclerotic Lesions , 2000 .
[14] L. Nencioni,et al. Mutants of pertussis toxin suitable for vaccine development. , 1989, Science.
[15] R. Poston,et al. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. , 1994, The American journal of pathology.
[16] R. Snyderman,et al. Chemoattractant Receptors Activate Distinct Pathways for Chemotaxis and Secretion , 1999, The Journal of Biological Chemistry.
[17] R. Ross,et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[18] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[19] K. Ley,et al. RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium , 2001, Circulation.
[20] A. Lusis,et al. Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium. , 1994, The Journal of clinical investigation.
[21] P. Groot,et al. Chemokines and atherosclerosis. , 1999, Atherosclerosis.
[22] P. Weber,et al. Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow , 1999, European journal of immunology.
[23] R. Ross,et al. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[24] C. Cochrane,et al. In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptors. , 1996, The Journal of laboratory and clinical medicine.
[25] Simon A. Jones,et al. Chemokine Antagonists That Discriminate between Interleukin-8 Receptors , 1997, The Journal of Biological Chemistry.
[26] T. Kita,et al. P-selectin and vascular cell adhesion molecule-1 are focally expressed in aortas of hypercholesterolemic rabbits before intimal accumulation of macrophages and T lymphocytes. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[27] A. Beaudet,et al. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[28] E. Leonard,et al. Human monocyte chemoattractant protein-1 (MCP-1). , 1990, Immunology today.
[29] D. Wagner,et al. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. , 2000, Circulation.
[30] W. Pearce,et al. Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. , 1993, American Journal of Pathology.
[31] I. Charo,et al. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.
[32] A. Lusis,et al. Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet. , 1999, Circulation research.
[33] J. Gong,et al. Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues , 1995, Journal of Experimental Medicine.
[34] B. Rollins,et al. Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. , 1994, The Journal of biological chemistry.
[35] E. Leonard,et al. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. , 1993, Human pathology.
[36] P. Huie,et al. RANTES chemokine expression in transplant-associated accelerated atherosclerosis. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[37] R. Gerrity. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981, The American journal of pathology.
[38] Gerrity Rg. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981 .
[39] C. Murdoch,et al. Chemokine receptors and their role in inflammation and infectious diseases. , 2000, Blood.
[40] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[41] Volker Herzog,et al. Establishment of a human cell line (mono mac 6) with characteristics of mature monocytes , 1988, International journal of cancer.
[42] J. Gong,et al. An Antagonist of Monocyte Chemoattractant Protein 1 (MCP-1) Inhibits Arthritis in the MRL-lpr Mouse Model , 1997, The Journal of experimental medicine.
[43] R. Ross,et al. Cell biology of atherosclerosis. , 1995, Annual review of physiology.
[44] B. Engelhardt,et al. Ligand-induced adhesion to activated endothelium and to vascular cell adhesion molecule-1 in lymphocytes transfected with the N-formyl peptide receptor. , 1994, Journal of immunology.
[45] E. Appella,et al. Human monocyte chemoattractant protein‐1 (MCP‐1) Full‐length cDNA cloning, expression in mitogen‐stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE , 1989, FEBS letters.
[46] K. Ley,et al. Mice lacking two or all three selectins demonstrate overlapping and distinct functions for each selectin. , 1999, Journal of immunology.
[47] P. Libby,et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.
[48] P. Blackmore,et al. Role of a guanine nucleotide-binding regulatory protein in the hydrolysis of hepatocyte phosphatidylinositol 4,5-bisphosphate by calcium-mobilizing hormones and the control of cell calcium. Studies utilizing aluminum fluoride. , 1985, The Journal of biological chemistry.
[49] F. Luscinskas,et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions , 1999, Nature.
[50] R. Gerrity,et al. The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. , 1981, The American journal of pathology.
[51] L. F. Kolakowski,et al. The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. , 1994, The Journal of biological chemistry.